Perkins Capital Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-13,700
| Closed | -$30K | – | 100 |
|
|
2023
Q2 | $30K | Sell |
13,700
-32,000
| -70% | -$70.1K | 0.03% | 92 |
|
|
2023
Q1 | $116K | Hold |
45,700
| – | – | 0.11% | 85 |
|
|
2022
Q4 | $85K | Sell |
45,700
-4,000
| -8% | -$7.44K | 0.09% | 84 |
|
|
2022
Q3 | $128K | Hold |
49,700
| – | – | 0.14% | 85 |
|
|
2022
Q2 | $96K | Hold |
49,700
| – | – | 0.1% | 91 |
|
|
2022
Q1 | $148K | Sell |
49,700
-10,500
| -17% | -$31.3K | 0.12% | 90 |
|
|
2021
Q4 | $270K | Sell |
60,200
-16,000
| -21% | -$71.8K | 0.18% | 85 |
|
|
2021
Q3 | $370K | Hold |
76,200
| – | – | 0.23% | 80 |
|
|
2021
Q2 | $520K | Buy |
76,200
+350
| +0.5% | +$2.39K | 0.3% | 72 |
|
|
2021
Q1 | $536K | Buy |
+75,850
| New | +$536K | 0.31% | 71 |
|